ArticleTrials2019

Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy.

Wesley de Jong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.